The Vectura Group Plc, a developer of respiratory therapies, has appointed Andrew J. Oakley as its chief financial officer and company secretary, effective 1 January 2015.
Mr Oakley was most recently CFO of Novimmune SA in Switzerland. Before that, he was CFO for nearly 11 years at Actelion Pharmaceuticals Ltd. He qualified as a chartered accountant in Australia and holds an MBA from the London Business School.
Vectura announced the appointment on 18 November 2014.
Copyright 2014 Evernow Publishing Ltd